Cargando…

Effectiveness and safety of non-vitamin K direct oral anticoagulants in atrial fibrillation patients with bioprosthetic valve

BACKGROUND: Non-vitamin K direct oral anticoagulant (DOAC) is effective for prevention of embolic events in nonvalvular atrial fibrillation (AF) patients. However, the effectiveness and safety of DOAC in AF patients who have bioprosthetic heart valve (BPHV) is largely unknown. METHODS: We retrospect...

Descripción completa

Detalles Bibliográficos
Autores principales:	Moon, Inki, Go, Tae-Hwa, Kim, Jang Young, Kang, Dae Ryong, Sohn, Suk Ho, Lee, Hyun-Jung, Choi, Jae-Woong, Park, Jun-Bean, Hwang, Ho-Young, Kim, Hyung-Kwan, Kim, Yong-Jin, Kim, Kyung-Hwan, Lee, Seung-Pyo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9197068/ https://www.ncbi.nlm.nih.gov/pubmed/35700183 http://dx.doi.org/10.1371/journal.pone.0268113

Ejemplares similares

Surgical Ablation of Atrial Fibrillation in Patients Undergoing Bioprosthetic Valve Replacement
por: Pyo, WonKyung, et al.
Publicado: (2019)

Bioprosthetic Valve Thrombosis while on a Novel Oral Anticoagulant for Atrial Fibrillation
por: O'Callaghan, Marissa, et al.
Publicado: (2018)

Comparative analysis of structural valve deterioration and long-term clinical outcomes after bovine pericardial versus porcine bioprosthetic mitral valve replacement
por: Kim, Woojung, et al.
Publicado: (2021)

Comparison of Sutureless Bioprosthetic Valve With Surgical or TAVR for Severe Aortic Stenosis
por: Kim, Ho Jin, et al.
Publicado: (2021)

Direct Oral Anticoagulants in Patients with Atrial Fibrillation and Bioprosthetic Valves—A Systematic Review and Meta-analysis
por: Ruzieh, Mohammed, et al.
Publicado: (2021)

Early Surgery versus Watchful Waiting in Patients with Moderate Aortic Stenosis and Left Ventricular Systolic Dysfunction
por: Moon, Inki, et al.
Publicado: (2020)

Marked changes in bioprosthetic valve thrombosis by anticoagulation therapy
por: Takasaki, Akihiro, et al.
Publicado: (2019)

First Asian Experience with the BASILICA Technique in Failed Bioprosthetic Aortic Valve
por: Kook, Hyungdon, et al.
Publicado: (2021)

Impact of postoperative duration of Aspirin use on longevity of bioprosthetic pulmonary valve in patients who underwent congenital heart disease repair
por: Hwang, Tae-Woong, et al.
Publicado: (2016)

Safety of direct oral anticoagulants compared to warfarin in cirrhotic patients with atrial fibrillation
por: Yoo, Seo Yeon, et al.
Publicado: (2022)

Gradient changes in bioprosthetic valve thrombosis: duration of anticoagulation and strategies to improve detection
por: Naser, Jwan A, et al.
Publicado: (2021)

Oral anticoagulation following bioprosthetic SAVR in patients with atrial fibrillation: what’s the current status of NOACs?
por: Milojevic, Milan, et al.
Publicado: (2022)

Bioprosthetic Valve Thrombosis
por: Sachdev, Sarina, et al.
Publicado: (2018)

Quality of Anticoagulation and Treatment Satisfaction in Patients with Non-Valvular Atrial Fibrillation Treated with Vitamin K Antagonist: Result from the KORean Atrial Fibrillation Investigation II
por: Oh, Seil, et al.
Publicado: (2018)

Trends in Oral Anticoagulation Therapy Among Korean Patients With Atrial Fibrillation: The KORean Atrial Fibrillation Investigation
por: Shin, Hong-Won, et al.
Publicado: (2012)

Acute thrombosis of bioprosthetic mitral valve
por: Kwon, Jin-Tae, et al.
Publicado: (2013)

Vascular Protective Effects of New Oral Anticoagulants in Patients with Atrial Fibrillation
por: Jang, Gyeong-Won, et al.
Publicado: (2021)

Progression of ascending aortopathy may not occur after transcatheter aortic valve replacement in severe bicuspid aortic stenosis
por: Jung, Ji-Hyun, et al.
Publicado: (2021)

The impact of beta-blocker use on postoperative atrial fibrillation after aortic valve replacement
por: Kim, Sue Hyun, et al.
Publicado: (2020)

Effectiveness and Safety of Off-label Dosing of Non–vitamin K Antagonist Anticoagulant for Atrial Fibrillation in Asian Patients
por: Lee, Kwang-No, et al.
Publicado: (2020)

The long-term outcomes of surgical ablation for atrial fibrillation during redo left-sided valvular surgery
por: Kang, Yoonjin, et al.
Publicado: (2023)

Anticoagulant Therapy-Induced Gallbladder Hemorrhage after Cardiac Valve Replacement
por: Cho, Seong Ho, et al.
Publicado: (2015)

Comparison of Renal Function Estimation Formulae for Dosing Direct Oral Anticoagulants in Patients with Atrial Fibrillation
por: Lee, Kwang-No, et al.
Publicado: (2019)

Rationale, Design, and Baseline Characteristics of the BioProsthetic Valves with Atrial Fibrillation (BPV-AF) Study
por: Furukawa, Yutaka, et al.
Publicado: (2020)

An Updated Meta-Analysis of DOACs vs. VKAs in Atrial Fibrillation Patients With Bioprosthetic Heart Valve
por: Cao, Yalin, et al.
Publicado: (2022)

The future of bioprosthetic heart valves
por: Manji, Rizwan A., et al.
Publicado: (2012)

Bioprosthetic mitral valve thrombosis
por: Bouwmeester, S., et al.
Publicado: (2022)

Bioprosthetic Aortic Valve on the Move
por: Milioglou, Ioannis, et al.
Publicado: (2022)

Perfusion parameters during cardiopulmonary bypass as a predictor of acute kidney injury after aortic valve replacement
por: Lee, Yeiwon, et al.
Publicado: (2021)

Practical Approach to Transcatheter Aortic Valve Implantation and Bioprosthetic Valve Fracture in a Failed Bioprosthetic Surgical Valve
por: Vanhaverbeke, Maarten, et al.
Publicado: (2022)

Infective Endocarditis Associated with Transcatheter Aortic Valve Replacement: Potential Importance of Local Trauma for a Deadly Nidus
por: Lee, Hak Seung, et al.
Publicado: (2014)

Functional Insufficiency of Mitral and Tricuspid Valves Associated With Atrial Fibrillation: Impact of Postoperative Atrial Fibrillation Recurrence on Surgical Outcomes
por: Kim, Kitae, et al.
Publicado: (2023)

Subclinical Valve Thrombosis in Sutureless Bioprosthetic Valves
por: Yanagawa, Bobby, et al.
Publicado: (2017)

Oral anticoagulant treatment after bioprosthetic valvular intervention or valvuloplasty in patients with atrial fibrillation—A SWEDEHEART study
por: Christersson, Christina, et al.
Publicado: (2022)

Prognosis of Atrial Fibrillation Patients Undergoing PCI According to Anticoagulants and Antiplatelet Agents
por: Yoon, Gwang-Seok, et al.
Publicado: (2021)

Safety and efficacy of direct oral anticoagulants in bioprosthetic valves: A systematic review and meta-analysis
por: Bakr, Lubna, et al.
Publicado: (2023)

Clinical impact of atrial fibrillation in a nationwide cohort of hypertrophic cardiomyopathy patients
por: Lee, Hyun-Jung, et al.
Publicado: (2020)

Impact of Anticoagulation Intensity in Korean Patients with Atrial Fibrillation: Is It Different from Western Population?
por: Lee, Ki Hong, et al.
Publicado: (2019)

Oral Anticoagulants for Atrial Fibrillation Patients with Active Cancer
por: Kim, Do Young, et al.
Publicado: (2018)

Clinical implication of right-sided augmentation pressure in patients with pulmonary hypertension
por: Sohn, Dae-Won, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_iai1bkb8spq5nm75i1kbto6ka4